List of companies in Sanofi Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard. | ||||||
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics. | ||||||
A biotechnology company specializing in creating therapeutics for neurological disorders. It was founded in 2014 and is located in New York City. | ||||||
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation. | ||||||
Evidation Health is a health and measurement company providing technical support to biopharmaceutical and healthcare companies. | ||||||
Abcuro develops immunotherapies to treat autoimmunity and cancer. | ||||||
A biotechnology company in Washington that focuses on developing safe and effective vaccines against infectious diseases. | ||||||
Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc. | ||||||
Yumanity Therapeutics was launched in 2014 by Susan Lindquist and Tony Coles. The scientific co-founders with Lindquist were Vikram Khurana, Daniel Tardiff and Chee-Yeun Chung. | ||||||
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. | ||||||
Lava Therapeutics is a biotechnology research company developing bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer. | ||||||
Small molecule compounds that act by unlocking protein-protein interfaces | ||||||
Click Therapeutics delivers safe and effective digital treatments to patients in need. | ||||||
Expansion Therapeutics is a RNA Targeted Small Molecules founded in 2016. | ||||||
Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018. | ||||||
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases | ||||||
MinervaX is a Copenhagen-based company founded in 2010 by Per Fischer. | ||||||
Science 37 is a company founded in 2014. | ||||||
Character Biosciences is a biopharmaceutical research and development company founded by Cheng Zhang. | ||||||
Nucleai is an AI-powered Tumor Micro Environment modeling founded in 2018 by Avi Veidman, Eliron Amir and Lotan Chorev. | ||||||
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases. | ||||||
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. | ||||||
Glycomine is an early-stage biotech working on replacement therapies for rare diseases. | ||||||
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases. | ||||||
